87 related articles for article (PubMed ID: 17030483)
1. Structural modifications of benzanilide derivatives, effective potassium channel openers. X.
Calderone V; Coi A; Fiamingo FL; Giorgi I; Leonardi M; Livi O; Martelli A; Martinotti E
Eur J Med Chem; 2006 Dec; 41(12):1421-9. PubMed ID: 17030483
[TBL] [Abstract][Full Text] [Related]
2. New amido derivatives as potential BKCa potassium channel activators. XI.
Calderone V; Fiamingo FL; Amato G; Giorgi I; Livi O; Martelli A; Martinotti E
Eur J Med Chem; 2008 Apr; 43(4):792-9. PubMed ID: 17692999
[TBL] [Abstract][Full Text] [Related]
3. Heterocyclic analogs of benzanilide derivatives as potassium channel activators. IX.
Calderone V; Fiamingo FL; Giorgi I; Leonardi M; Livi O; Martelli A; Martinotti E
Eur J Med Chem; 2006 Jun; 41(6):761-7. PubMed ID: 16626840
[TBL] [Abstract][Full Text] [Related]
4. 1,2,3-Triazol-carboxanilides and 1,2,3-triazol-(N-benzyl)-carboxamides as BK-potassium channel activators. XII.
Calderone V; Fiamingo FL; Amato G; Giorgi I; Livi O; Martelli A; Martinotti E
Eur J Med Chem; 2008 Nov; 43(11):2618-26. PubMed ID: 18400336
[TBL] [Abstract][Full Text] [Related]
5. Benzoyl and/or benzyl substituted 1,2,3-triazoles as potassium channel activators. VIII.
Calderone V; Giorgi I; Livi O; Martinotti E; Mantuano E; Martelli A; Nardi A
Eur J Med Chem; 2005 Jun; 40(6):521-8. PubMed ID: 15922836
[TBL] [Abstract][Full Text] [Related]
6. 1,4- and 2,4-substituted-1,2,3-triazoles as potential potassium channel activators. VII.
Calderone V; Giorgi I; Livi O; Martinotti E; Martelli A; Nardi A
Farmaco; 2005 May; 60(5):367-75. PubMed ID: 15910810
[TBL] [Abstract][Full Text] [Related]
7. Natural modulators of large-conductance calcium-activated potassium channels.
Nardi A; Calderone V; Chericoni S; Morelli I
Planta Med; 2003 Oct; 69(10):885-92. PubMed ID: 14648389
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological activity of novel substituted benzanilides as potassium channel activators. V.
Biagi G; Giorgi I; Livi O; Nardi A; Calderone V; Martelli A; Martinotti E; LeRoy Salerni O
Eur J Med Chem; 2004 Jun; 39(6):491-8. PubMed ID: 15183907
[TBL] [Abstract][Full Text] [Related]
9. Voltage-sensitive oxonol dyes are novel large-conductance Ca2+-activated K+ channel activators selective for beta1 and beta4 but not for beta2 subunits.
Morimoto T; Sakamoto K; Sade H; Ohya S; Muraki K; Imaizumi Y
Mol Pharmacol; 2007 Apr; 71(4):1075-88. PubMed ID: 17209121
[TBL] [Abstract][Full Text] [Related]
10. Novel 1,4-benzothiazine derivatives as large conductance Ca2+-activated potassium channel openers.
Calderone V; Spogli R; Martelli A; Manfroni G; Testai L; Sabatini S; Tabarrini O; Cecchetti V
J Med Chem; 2008 Aug; 51(16):5085-92. PubMed ID: 18680269
[TBL] [Abstract][Full Text] [Related]
11. 5-(4'-Substituted-2'-nitroanilino)-1,2,3-triazoles as new potential potassium channel activators. I.
Biagi G; Calderone V; Giorgi I; Livi O; Scartoni V; Baragatti B; Martinotti E
Eur J Med Chem; 2000; 35(7-8):715-20. PubMed ID: 10960187
[TBL] [Abstract][Full Text] [Related]
12. Activation of large-conductance calcium-activated potassium channels by puerarin: the underlying mechanism of puerarin-mediated vasodilation.
Sun XH; Ding JP; Li H; Pan N; Gan L; Yang XL; Xu HB
J Pharmacol Exp Ther; 2007 Oct; 323(1):391-7. PubMed ID: 17652634
[TBL] [Abstract][Full Text] [Related]
13. Some structural changes on triazolyl-benzotriazoles and triazolyl-benzimidazolones as potential potassium channel activators. III.
Biagi G; Calderone V; Giorgi I; Livi O; Scartoni V; Baragatti B; Martinotti E
Farmaco; 2001 Nov; 56(11):841-9. PubMed ID: 11765036
[TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of hydroxy-alkynoic acids and their methyl esters as novel activators of BK channels.
Patil S; Bukiya AN; Li W; Dopico AM; Miller D
Bioorg Med Chem Lett; 2008 Jun; 18(11):3427-30. PubMed ID: 18462939
[TBL] [Abstract][Full Text] [Related]
15. 6-Substituted benzopyrans as potassium channel activators: synthesis, vasodilator properties, and multivariate analysis.
Mannhold R; Cruciani G; Weber H; Lemoine H; Derix A; Weichel C; Clementi M
J Med Chem; 1999 Mar; 42(6):981-91. PubMed ID: 10090781
[TBL] [Abstract][Full Text] [Related]
16. N-aryl-3,3,3-trifluoro-2-hydroxy-2-methylpropanamides: KATP potassium channel openers. Modifications on the western region.
Ohnmacht CJ; Russell K; Empfield JR; Frank CA; Gibson KH; Mayhugh DR; McLaren FM; Shapiro HS; Brown FJ; Trainor DA; Ceccarelli C; Lin MM; Masek BB; Forst JM; Harris RJ; Hulsizer JM; Lewis JJ; Silverman SM; Smith RW; Warwick PJ; Kau ST; Chun AL; Grant TL; Howe BB; Neilson KL
J Med Chem; 1996 Nov; 39(23):4592-601. PubMed ID: 8917648
[TBL] [Abstract][Full Text] [Related]
17. The amiodarone derivative 2-methyl-3-(3,5-diiodo-4-carboxymethoxybenzyl)benzofuran (KB130015) opens large-conductance Ca2+-activated K+ channels and relaxes vascular smooth muscle.
Gessner G; Heller R; Hoshi T; Heinemann SH
Eur J Pharmacol; 2007 Jan; 555(2-3):185-93. PubMed ID: 17134694
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and BK channel-opening activity of hexahydrodibenzazepinone derivatives.
Tashima T; Toriumi Y; Mochizuki Y; Nonomura T; Nagaoka S; Furukawa K; Tsuru H; Adachi-Akahane S; Ohwada T
Bioorg Med Chem; 2006 Dec; 14(23):8014-31. PubMed ID: 16904328
[TBL] [Abstract][Full Text] [Related]
19. Spirocyclic benzopyran-based derivatives as new anti-ischemic activators of mitochondrial ATP-sensitive potassium channel.
Breschi MC; Calderone V; Digiacomo M; Manganaro M; Martelli A; Minutolo F; Rapposelli S; Testai L; Tonelli F; Balsamo A
J Med Chem; 2008 Nov; 51(21):6945-54. PubMed ID: 18925735
[TBL] [Abstract][Full Text] [Related]
20. Stimulation of Ca2+-gated Cl- currents by the calcium-dependent K+ channel modulators NS1619 [1,3-dihydro-1-[2-hydroxy-5-(trifluoromethyl)phenyl]-5-(trifluoromethyl)-2H-benzimidazol-2-one] and isopimaric acid.
Saleh SN; Angermann JE; Sones WR; Leblanc N; Greenwood IA
J Pharmacol Exp Ther; 2007 Jun; 321(3):1075-84. PubMed ID: 17347326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
